Price $153.49 |
Market Cap
237.7B
|
Sector Health Care |
Div. Growth
7.50%
|
|
P/E
31.8
|
P/B
17.97
|
P/S
4.2
|
Dividend %
4.40%
|
|
P/CF
385.7
|
P/FCF
18.0
|
Op. Cash Flow
24.23M
|
FCF
7.5
|
|
Op. Margin
28.50%
|
Net Margin
13.30%
|
ROE
49.30%
|
ROI
20.50%
|
|
ROA
5.40%
|
EPS Growth
-39.30%
|
Current Ratio
1.0
|
Debt/Equity
342.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bellerophon Therapeutics Inc (BLPH) | $0.39 | - | - | 7.2M | Strong Buy |
| Accelerate Diagnostics Inc (AXDX) | $6.11 | - | - | 80.9M | Strong Buy |
| Immunome Inc (IMNM) | $7.26 | - | - | 96.6M | Strong Buy |
| Avinger Inc (AVGR) | $10.45 | - | - | 7.8M | Strong Buy |
| Inotiv Inc (NOTV) | $3.15 | - | - | 122.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
